Robert Hazlett

Stock Analyst at BTIG

(2.54)
# 806
Out of 5,243 analysts
47
Total ratings
36.00%
Success rate
77.04%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Aura Biosciences
Maintains: Strong Buy
21 24
7.72 210.88% 3 Oct 18, 2024
Nektar Therapeutics
Assumes: Buy
4
0.9 344.44% 2 Sep 30, 2024
Rani Therapeutics Hl...
Maintains: Strong Buy
7 14
1.31 968.7% 2 May 9, 2024
Aravive
Downgrades: Neutral
n/a
n/a n/a 2 Aug 3, 2023
Seelos Therapeutics
Maintains: Buy
42240 15360
n/a n/a 5 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 20
0.19 10426.32% 1 Feb 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
62 98
93.92 4.34% 2 Dec 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
96 60
5.33 1025.7% 3 Oct 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1710 1440
n/a n/a 1 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
522 216
n/a n/a 3 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Feb 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
15
0.05 29900% 3 Dec 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
n/a n/a 1 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
63
3.44 1731.4% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
280
0.03 933233.33% 2 Apr 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
29
13.23 119.2% 4 Feb 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 40
126.85 -68.47% 2 Nov 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26000
5.59 465016.28% 1 Sep 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 6
1.94 209.28% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 27
7.85 243.95% 2 Oct 16, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
n/a n/a 1 Aug 31, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
13
n/a n/a 1 Apr 21, 2017